Company offers 72 million common shares at $0.50 apiece to Bergamo
By Devika Patel
Knoxville, Tenn., April 10 - VistaGen Therapeutics, Inc. said it will raise $36 million in a private placement of stock with a subsidiary of Bergamo Acquisition Corp.
The company will sell 72 million common shares at $0.50 apiece. The per-share price represents a 33.33% discount to the April 9 closing share price of $0.75.
Settlement is expected April 30.
Proceeds will be used to accelerate and expand the company's stem cell technology-based drug rescue programs.
The company is a South San Francisco, Calif.-based biotechnology company focused on stem cell technology for drug rescue, toxicology and drug metabolism assays.
| Issuer: | VistaGen Therapeutics, Inc.
|
| Issue: | Common stock
|
| Amount: | $36 million
|
| Shares: | 72 million
|
| Price: | $0.50
|
| Warrants: | No
|
| Investor: | Bergamo Acquisition Corp.
|
| Pricing date: | April 10
|
| Settlement date: | April 30
|
| Stock symbol: | OTCBB: VSTA
|
| Stock price: | $0.75 at close April 9
|
| Market capitalization: | $17.48 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
